Teclison Ltd.

This early-phase study tests a drug called tirapazamine, which becomes active in low-oxygen areas, combined with a procedure that blocks blood flow to liver tumors (embolization). The goal is to find the safest and most effective dose for people with liver cancer or liver-dominan…

This study tests a two-step treatment for people with advanced liver cancer or stomach cancer that has spread to the liver. First, a drug called tirapazamine is injected directly into the liver's blood vessels to block and kill tumor cells. Then, patients receive nivolumab, an im…

This study tests a two-part treatment for people with colorectal or non-small cell lung cancer that has spread to the liver. The treatment combines a procedure that delivers a drug directly to liver tumors (TATE) with an immunotherapy drug (pembrolizumab) that helps the immune sy…